Danish Pharmacovigilance Update, April 2017

In this issue

• Ciprofloxacin and risk of polyneuropathy and tendon disease/disorder
• Rosuvastatin and risk of renal effects and rhabdomyolysis
• The DKMA’s annual pharmacovigilance report 2016
• Report on the use of and ADR reports on selected biological medicinal products now available
• EU's list of recommendations on safety signals
• Most recent Direct Healthcare Professional Communications (DHPCs)

Link

Danish Pharmacovigilance Update, April 2017